After Surging 53% in 2023, This Pharmaceutical Stock Might Be About to Crash. Here ' s Why I ' m Probably Wrong

Artificial intelligence (AI) wasn't the only big investment theme last year. The pharmaceutical industry saw increased interest due to the popularity of new weight-monitoring treatments. In particular, Danish drug manufacturer Novo Nordisk (NYSE: NVO) enjoyed tailwinds fueled by demand over its…#danish #novonordisk #nvo #ozempic #saxenda #magic #pilot #glp1 #wegovy #elililly

Source: Reuters: Health - January 13, 2024 Category: Consumer Health News Source Type: news